Conakry

Resilience System


You are here

Home › Pfizer, BioNTech's updated booster protects against Omicron in human trial › Pfizer, BioNTech's updated booster protects against Omicron in human trial

Pfizer, BioNTech's updated booster protects against Omicron in human trial

Primary tabs

Pfizer, BioNTech's updated booster protects against Omicron in human trial

Thu, 2022-10-13 14:14 — mike kraft
Pfizer, BioNTech's updated booster protects against Omicron in human trial Pfizer and its German partner BioNTech said their COVID-19 vaccine booster, adapted for the BA.4 and the BA.5 subvariants, generated a strong immune response and was well tolerated in testing on humans. Ludwig Burger,Manas Mishra Reuters

...

With the results, which the companies described as consistent with preclinical data, the partners are following up with human trial data that had previously been missing from their successful filings for regulatory approval. ...

 

Country / Region Tags: 
Germany
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Data
Disease
Disease Prevention
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks